Gliomas, a prevalent category of primary malignant brain tumors, pose formidable clinical
challenges due to their invasive nature and limited treatment options. The current …

Abnormalities of several oncogenes and tumor suppressor genes have been identified in
carcinomas during the last decade and of pathological warfare and physiological traits, and …

A major unmet need in the cystic fibrosis (CF) therapeutic landscape is the lack of effective
treatments for nonsense CFTR mutations, which affect approximately 10% of CF patients …

Gliomas are the most common primary central nervous system tumors, with a high mortality
rate. Early and accurate diagnosis of gliomas is critical for successful treatment. Biosensors …

Glioblastoma, an aggressive primary brain tumor, poses a significant challenge owing to its
dynamic and intricate tumor microenvironment. This review investigates the innovative …

Glioblastoma is the most common and aggressive central nervous system tumor in adults
with a 6% survival rate. Decades of research for improving life expectancy and quality of life …

In patients with low-grade gliomas (LGG), the prognosis is significantly favorable in those
with 1p/19q codeletion than in those with 1p/19q intact. Although 1p/19q codeletion has …

Gliomas, a prevalent category of primary malignant brain tumors, pose formidable clinical
challenges due to their invasive nature and limited treatment options. The current …